Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis

European Journal of Surgical Oncology

Volumn 43, Issue 8, 2017, Pages 1463-1471

  Handgraaf, H J M ^a   Boogerd, L S F ^a   Hoppener D J ^a   Peloso, A ^b   Sibinga Mulder, B G ^a   Hoogstins, C E S ^a   Hartgrink, H H ^a   van de Velde, C J H ^a   Mieog, J S D ^a   Swijnenburg, R J ^a   Putter, H ^a   Maestri, M ^b   Braat, A E ^a   Frangioni, J V ^c   Vahrmeijer, A L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PAVIA   (Italy)

^c Curadel LLC   (United States)

Author keywords

Cancer; Fluorescence imaging; Indocyanine green; Liver neoplasms; Prognosis; Surgery

Indexed keywords

INDOCYANINE GREEN; FLUORESCENT DYE;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; COHORT ANALYSIS; COLORECTAL LIVER METASTASIS; FEMALE; FLUORESCENCE IMAGING; FLUORESCENCE IMAGING SYSTEM; FOLLOW UP; HEMIHEPATECTOMY; HUMAN; LAPAROSCOPE; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NEAR INFRARED FLUORESCENCE IMAGING; OVERALL SURVIVAL; PALPATION; PERIOPERATIVE PERIOD; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REOPERATION; RETROSPECTIVE STUDY; CLINICAL TRIAL; COLORECTAL TUMOR; COMPUTER ASSISTED SURGERY; FLUORESCENCE MICROSCOPY; LIVER NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; SECONDARY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY;

COLORECTAL NEOPLASMS; FEMALE; FLUORESCENT DYES; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; LIVER NEOPLASMS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 85020076717     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2017.04.016     Document Type: Article

References (29)

1. Wei, A.C., Greig, P.D., Grant, D., Taylor, B., Langer, B., Gallinger, S., Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13 (2006), 668–676.
2. Abdalla, E.K., Vauthey, J.N., Ellis, L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004), 818–825 discussion 25–7.
3. Rees, M., Tekkis, P.P., Weilsh, F.K., O'Rourke, T., John, T.G., Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247 (2008), 125–135.
4. Karanjia, N.D., Lordan, J.T., Fawcett, W.J., Quiney, N., Worthington, R.T., Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases: a ten year study. Eur J Surg Oncol 35 (2009), 838–843.
5. Frankel, T.L., Gian, R.K., Jarnagin, W.R., Preoperative imaging for hepatic resection of colorectal cancer metastasis. J Gastrointest Oncol 3 (2012), 11–18.
6. Khalil, H., Patterson, S.A., Panicek, D.M., Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 235 (2005), 872–878.
7. Holzapfel, K., Reiser-Erkan, C., Fingerle, A.A., et al. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging 36 (2011), 179–184.
8. Vahrmeijer, A.L., Hutteman, M., van der Vorst, J.R., van de Velde, C.J., Frangioni, J.V., Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10 (2013), 507–518.
9. Stummer, W., Pichlmeier, U., Meinel, T., et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7 (2006), 392–401.
10. Stummer, W., Novorny, A., Stepp, H., Goetz, C., Bise, K., Reulen, H.J., Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93 (2000), 1003–1013.
11. Stummer, W., Stocker, S., Wagner, S., et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42 (1998), 518–525 discussion 25–6.
12. Ishizawa, T., Fukushima, N., Shibahara, J., et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 115 (2009), 2491–2504.
13. Ishizuka, M., Kubota, K., Kita, J., Shimoda, M., Kato, M., Sawada, T., Intraoperative observation using a fluorescence imaging instrument during hepatic resection for liver metastasis from colorectal cancer. Hepatogastroenterology 59 (2012), 90–92.
14. Kaibori, M., Matsui, K., Ishizaki, M., et al. Intraoperative detection of superficial liver tumors by fluorescence imaging using indocyanine green and 5-aminolevulinic acid. Anticancer Res 36 (2016), 1841–1849.
15. van der Vorst, J.R., Schaafsma, B.E., Hutteman, M., et al. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer 119 (2013), 3411–3418.
16. Peloso, A., Franchi, E., Canepa, M.C., et al. Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer. HPB (Oxford) 15 (2013), 928–934.
17. Boogerd, L.S., Handgraaf, H.J., Lam, H.D., et al. Laparoscopic detection and resection of occult liver tumors of multiple cancer types using real-time near-infrared fluorescence guidance. Surg Endosc 31:2 (2017), 952–961.
18. Barabino, G., Porcheron, J., Cottier, M., et al. Improving surgical resection of metastatic liver tumors with near-infrared optical-guided fluorescence imaging. Surg Innov 23 (2016), 354–359.
19. Benya, R., Quintana, J., Brundage, B., Adverse reactions to indocyanine green: a case report and a review of the literature. Cathet Cardiovasc Diagn 17 (1989), 231–233.
20. Rosenthal, E.L., Warram, J.M., de Boer, E., et al. Successful translation of fluorescence navigation during oncologic surgery: a consensus report. J Nucl Med 57 (2016), 144–150.
21. Fong, Y., Fortner, J., Sun, R.L., Brennan, M.F., Blumgart, L.H., Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999), 309–318 discussion 18–21.
22. Troyan, S.L., Kianzad, V., Gibbs-Straus, S.L., et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16 (2009), 2943–2952.
23. van Driel, P.B., van de Giessen, M., Boonstra, M.C., et al. Characterization and evaluation of the artemis camera for fluorescence-guided cancer surgery. Mol Imaging Biol 17 (2015), 413–423.
24. Boogerd, L.S., Handgraaf, H.J., Lam, H.D., et al. Application of near-infrared fluorescence imaging during modified associating liver partition and portal vein ligation for staged hepatectomy. Surgery 159 (2016), 1481–1482.
25. Nordlinger, B., Sorbye, H., Glimelius, B., et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14 (2013), 1208–1215.
26. Handgraaf, H.J., Verbeek, F.P., Tummers, Q.R., et al. Real-time near-infrared fluorescence guided surgery in gynecologic oncology: a review of the current state of the art. Gynecol Oncol 135 (2014), 606–613.
27. Hoogstins, C.E., Tummers, Q.R., Gaarenstroom, K.N., et al. A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer. Clin Cancer Res 22 (2016), 2929–2938.
28. Rosenthal, E.L., Warram, J.M., de Boer, E., et al. Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer. Clin Cancer Res 21 (2015), 3658–3666.
29. Lamberts, L.E., Koch, M., de Jong, J.S., et al. Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study. Clin Cancer Res, 2016, 10.1158/1078-0432.CCR-16-0437 [Epub ahead of print].